77 results
DEFA14A
SYRS
Syros Pharmaceuticals Inc.
23 Apr 24
Additional proxy soliciting materials
7:05am
Additional Materials
Soliciting Material Pursuant to §240.14a-12
SYROS PHARMACEUTICALS, INC.
(Name of Registrant as Specified in Its Charter)
(Name … with preliminary materials
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
+ Online Go
PRE 14A
SYRS
Syros Pharmaceuticals Inc.
12 Apr 24
Preliminary proxy
4:30pm
Additional Materials
Soliciting Material Pursuant to §240.14a-12
SYROS PHARMACEUTICALS, INC.
(Name of Registrant as Specified in Its Charter)
(Name … with preliminary materials
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
PRELIMINARY PROXY
8-K
EX-1.1
thfod54eqy6zyaqnjf
19 Dec 23
Syros Announces Pricing of $45.0 million Underwritten Offering of Common Stock and Pre-Funded Warrants
4:59pm
DEFA14A
ob7s0ry0q
21 Apr 23
Additional proxy soliciting materials
7:03am
D
f2tp 9cj08
21 Sep 22
$129.84M in equity / options, sold $129.84M, 19 investors
5:07pm
424B3
co0hhd4a
8 Aug 22
Prospectus supplement
5:47pm
S-4/A
EX-99.2
siz391t
1 Aug 22
Registration of securities issued in business combination transactions (amended)
9:01am
S-4
oeqcro5
18 Jul 22
Registration of securities issued in business combination transactions
7:58am
425
wbz x4133dejewmte8aq
5 Jul 22
Business combination disclosure
7:14am